Form TA-1/A SEI Institutional Transf
Tweet
Share
E-mailhttp://archive.fast-edgar.com/20250522/AD2A522CZ222W2Z2222422EZ5LT3ZL626272
Filed on: May 15, 2025
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wrightwell Appoints Craig Krandel as Managing Director, Head of Capital Markets
- Marketing Veteran Bryan Dulaney is advising SafeSpace Global on Growth Strategy
- Meiji Seika Pharma: Results from the Global Phase III Trial (Integral-2) of Nacubactam, a Novel β-Lactamase Inhibitor, Highlighted in The Lancet Microbe’s Coverage of ESCMID Global Congress 2026
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
